Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ORIG3N, announced the launch of a unique partnership with Innovasalud to bring health and wellness DNA Tests to Latin America.
read more
SGS announced it has expanded storage capacity at its laboratory in Mississauga, Canada.
read more
BrainStorm has begun training City of Hope's Center for Biomedicine and Genetics to produce NurOwn adult stem cells for the ALS Phase 3 clinical study.
read more
Neal Cutler, M.D., Chief Executive Officer of Worldwide Clinical Trials, has been named by the 2017 European CEO Awards as the “Best CEO in the CRO Industry.”
read more
Kemwell Biopharma announced it has manufactured and supplied drug substance in India for clinical trials that will be performed by its customer in USA for an IND filing.
read more
PharmaMar announced an agreement with Specialised Therapeutics Asia to market the marine-based anti-tumour compound of the company, lurbinectedin.
read more
Seventh Wave Laboratories has announced an exclusive collaboration with Yecuris Corporation.
read more
Heptares has been notified by Teva a preclinical candidate calcitonin gene-related peptide antagonist has been nominated for advancement as an investigational treatment for migraine.
read more
Thermo Fisher announced it has entered into an agreement with Agios to develop and commercialize a next-generation sequencing oncology companion diagnostic for ivosidenib to identify isocitrate dehydrogenase 1 mutations in cholangiocarcinoma patients...
read more
DelMar Pharmaceuticals announced the closing of a $9 million offering of common stock and warrants which was led by leading healthcare dedicated institutional investors.
read more
Clinipace Worldwide appointed Eric B. Grossman, MD, as Vice President and Medical Director.
read more
CollPlant announced it has signed a new, exclusive distributor agreement in Turkey to market Vergenix FG, for the treatment of chronic wounds.
read more
UPM announced it is celebrating the 100 year anniversary of pharmaceutical manufacturing occurring at its Bristol, Tennessee facility.
read more
BioVectra announced its fourth cGMP facility will be fully operational by December 2017.
read more
Evotec AG announced its multi-target endometriosis alliance with Bayer has reached another significant pre-clinical milestone, triggering a payment of approx. EUR 5 m to Evotec for the transition of a program into pre-clinical development for the ...
read more